TNFRSF25 and osteoporosis: While roles for DR3 and its ligand TL1A have been demonstrated in numerous conditions that are associated with pathological bone loss [13–15], it is currently unknown whether DR3 and / or TL1A are affected by loss of oestrogen and contribute to the progression of menopause-induced primary osteoporosis.